Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × Imatinib Mesylate × Clear all

NCT02127372 2014-09-15

Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571

Phase 1/2 Terminated

43 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms